I regard golf as an expensive way of playing marbles." - G.K. Chesterton
Today, we circle back on a 'Tier 3' biopharma concern that we have not looked at in some time. We revisit this name in the in-depth analysis presented below.
Company Overview:
Radius Health, Inc. (RDUS) is a Waltham, Massachusetts based commercial-stage biopharmaceutical concern focused on the development of therapies for osteoporosis and endocrine diseases. The company currently has one commercial asset, anabolic therapy, TYMLOS. It is also conducting three Phase 3 trials that include label expansion and transdermal delivery